News & Analysis on Clinical Trial Services & Contract Research And Development
US demand for drug delivery systems is set to increase by over 10 per cent a year, reaching $132bn in 2012 with growth driven by injectable biologic dugs, according to a new study by the Freedonia Group.
Two products aimed at enhancing the efficiency of process development in biopharmaceutical manufacturing are the latest offerings from GE Healthcare, the UK-based medical technology and services company.
Stiefel Laboratories, Biopharm Services, Multisorb Technologies, the Pharmaceutical Research and Manufacturers of America, Catalent Pharma Solutions and Chromatide have all had people on the move in the world of pharmaceutical manufacturing.
US-based Delcath Systems has achieved positive results in treating diffuse liver cancer using its percutaneous hepatic perfusion (PHP) delivery system.